Update: 04.03.2025
Last week: 8 week 2024 (17.02.2025 - 23.02.2025)
Last full month: January 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 489 | 0.4% | 13.1% | 0.8 | 20 624 897 | -0.5% | 9.8% | 0.5 | -5.8% |
| MoM | 33 837 | -14.9% | 12.9% | -0.6 | 69 344 094 | -8.9% | 9.3% | -0.2 | -11.2% |
| YTD | 65 899 | 27.5% | 12.8% | 1.7 | 138 783 752 | 19.6% | 9.4% | -0.2 | 10.3% |
| MAT | 435 644 | 23.5% | 12.6% | 3.1 | 861 845 441 | 22.9% | 9.3% | 1.3 | -7.2% |
| BRAINMAX | |||||||||
| WoW | 2 336 | -0.8% | 100.0% | 0 | 8 082 429 | -2.5% | 100.0% | 0 | -0.8% |
| MoM | 8 486 | -17.2% | 100.0% | 0 | 30 256 382 | -13.9% | 100.0% | 0 | -17.2% |
| YTD | 16 621 | 118.6% | 100.0% | 0 | 58 612 165 | 115.3% | 100.0% | 0 | 118.6% |
| MAT | 91 682 | 82.9% | 100.0% | 0 | 318 107 931 | 82.5% | 100.0% | 0 | 82.9% |
| GOLDLINE PLUS | |||||||||
| WoW | 16 018 | -8.9% | 45.4% | 0.6 | 51 347 096 | -10.6% | 36.3% | -0.1 | -10.0% |
| MoM | 65 341 | 9.4% | 45.4% | -1.2 | 211 436 517 | 11.8% | 37.6% | -0.3 | 12.2% |
| YTD | 122 329 | -2.1% | 45.2% | 1.8 | 397 178 332 | -1.8% | 37.1% | 1.3 | -6.0% |
| MAT | 826 414 | -5.7% | 45.7% | 0.5 | 2 595 641 917 | -5.3% | 37.4% | -2 | -6.7% |
| MIGRENIUM | |||||||||
| WoW | 8 260 | -13.1% | 0.3% | 0 | 2 853 543 | -12.8% | 0.5% | 0 | -4.4% |
| MoM | 33 141 | -10.0% | 0.3% | 0 | 11 562 682 | -10.1% | 0.5% | 0 | -4.3% |
| YTD | 64 433 | -32.8% | 0.4% | -0.2 | 22 348 188 | -14.5% | 0.5% | -0.1 | 0.4% |
| MAT | 536 416 | -16.7% | 0.5% | -0.1 | 177 854 850 | 34.8% | 0.6% | 0.1 | 0.6% |
| MODELAX-N | |||||||||
| WoW | 33 921 | -7.7% | 22.1% | -1.3 | 17 547 950 | -7.0% | 15.7% | -0.9 | -2.1% |
| MoM | 131 900 | 12.7% | 21.1% | 2.5 | 67 843 771 | 14.2% | 14.8% | 1.8 | -0.4% |
| YTD | 253 885 | 10.8% | 21.8% | 0.5 | 130 614 621 | 42.0% | 15.3% | 2.5 | 8.1% |
| MAT | 1 488 346 | 18.6% | 21.8% | 2.5 | 697 929 206 | 62.8% | 14.6% | 3.7 | 5.2% |
| REDUXIN | |||||||||
| WoW | 11 377 | -11.2% | 32.3% | -0.4 | 64 215 814 | -10.0% | 45.4% | 0.2 | -10.0% |
| MoM | 45 654 | 12.6% | 31.7% | 0.1 | 244 184 975 | 11.5% | 43.5% | -0.4 | 12.2% |
| YTD | 86 643 | -10.5% | 32.0% | -1.6 | 471 830 449 | -10.2% | 44.1% | -2.4 | -6.0% |
| MAT | 585 263 | -7.7% | 32.4% | -0.4 | 3 109 574 433 | 4.6% | 44.8% | 2 | -6.7% |
| REDUXIN FORTE | |||||||||
| WoW | 3 548 | -12.2% | 10.1% | -0.2 | 15 948 385 | -11.6% | 11.3% | -0.1 | -10.0% |
| MoM | 14 054 | 12.6% | 9.8% | 0 | 63 041 555 | 12.9% | 11.2% | 0 | 12.2% |
| YTD | 27 106 | 7.8% | 10.0% | 1.3 | 121 430 794 | 8.4% | 11.3% | 1.4 | -6.0% |
| MAT | 169 307 | 0.6% | 9.4% | 0.7 | 731 107 468 | 7.3% | 10.5% | 0.7 | -6.7% |
| SALVISAR | |||||||||
| WoW | 15 548 | -13.3% | 2.1% | -0.1 | 7 493 105 | -12.6% | 2.0% | -0.1 | -7.4% |
| MoM | 54 730 | -5.1% | 1.8% | -0.1 | 25 850 376 | -1.0% | 1.7% | 0 | -2.3% |
| YTD | 112 086 | 75.8% | 2.0% | 0.9 | 53 244 844 | 133.5% | 1.9% | 1 | -4.1% |
| MAT | 620 113 | 30.0% | 1.6% | 0.4 | 271 386 614 | 70.6% | 1.5% | 0.5 | -6.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 65 899 | 27.5% | 12.8% | 1.7 | 138 783 752 | 19.6% | 9.4% | -0.2 | 10.3% |
| BRAINMAX | 16 621 | 118.6% | 100.0% | 0 | 58 612 165 | 115.3% | 100.0% | 0 | 118.6% |
| GOLDLINE PLUS | 122 329 | -2.1% | 45.2% | 1.8 | 397 178 332 | -1.8% | 37.1% | 1.3 | -6.0% |
| MIGRENIUM | 64 433 | -32.8% | 0.4% | -0.2 | 22 348 188 | -14.5% | 0.5% | -0.1 | 0.4% |
| MODELAX-N | 253 885 | 10.8% | 21.8% | 0.5 | 130 614 621 | 42.0% | 15.3% | 2.5 | 8.1% |
| REDUXIN CAPS | 86 643 | -10.5% | 32.0% | -1.6 | 471 830 449 | -10.2% | 44.1% | -2.4 | -6.0% |
| REDUXIN FORTE | 27 106 | 7.8% | 10.0% | 1.3 | 121 430 794 | 8.4% | 11.3% | 1.4 | -6.0% |
| SALVISAR | 112 086 | 75.8% | 2.0% | 0.9 | 53 244 844 | 133.5% | 1.9% | 1 | -4.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 435 644 | 23.5% | 12.6% | 3.1 | 861 845 441 | 22.9% | 9.3% | 1.3 | -7.2% |
| BRAINMAX | 91 682 | 82.9% | 100.0% | 0 | 318 107 931 | 82.5% | 100.0% | 0 | 82.9% |
| GOLDLINE PLUS | 826 414 | -5.7% | 45.7% | 0.5 | 2 595 641 917 | -5.3% | 37.4% | -2 | -6.7% |
| MIGRENIUM | 536 416 | -16.7% | 0.5% | -0.1 | 177 854 850 | 34.8% | 0.6% | 0.1 | 0.6% |
| MODELAX-N | 1 488 346 | 18.6% | 21.8% | 2.5 | 697 929 206 | 62.8% | 14.6% | 3.7 | 5.2% |
| REDUXIN CAPS | 585 263 | -7.7% | 32.4% | -0.4 | 3 109 574 433 | 4.6% | 44.8% | 2 | -6.7% |
| REDUXIN FORTE | 169 307 | 0.6% | 9.4% | 0.7 | 731 107 468 | 7.3% | 10.5% | 0.7 | -6.7% |
| SALVISAR | 620 113 | 30.0% | 1.6% | 0.4 | 271 386 614 | 70.6% | 1.5% | 0.5 | -6.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 489 | 0.4% | 13.1% | 0.8 | 20 624 897 | -0.5% | 9.8% | 0.5 | -5.8% |
| BRAINMAX | 2 336 | -0.8% | 100.0% | 0 | 8 082 429 | -2.5% | 100.0% | 0 | -0.8% |
| GOLDLINE PLUS | 16 018 | -8.9% | 45.4% | 0.6 | 51 347 096 | -10.6% | 36.3% | -0.1 | -10.0% |
| MIGRENIUM | 8 260 | -13.1% | 0.3% | 0 | 2 853 543 | -12.8% | 0.5% | 0 | -4.4% |
| MODELAX-N | 33 921 | -7.7% | 22.1% | -1.3 | 17 547 950 | -7.0% | 15.7% | -0.9 | -2.1% |
| REDUXIN CAPS | 11 377 | -11.2% | 32.3% | -0.4 | 64 215 814 | -10.0% | 45.4% | 0.2 | -10.0% |
| REDUXIN FORTE | 3 548 | -12.2% | 10.1% | -0.2 | 15 948 385 | -11.6% | 11.3% | -0.1 | -10.0% |
| SALVISAR | 15 548 | -13.3% | 2.1% | -0.1 | 7 493 105 | -12.6% | 2.0% | -0.1 | -7.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 33 837 | -14.9% | 12.9% | -0.6 | 69 344 094 | -8.9% | 9.3% | -0.2 | -11.2% |
| BRAINMAX | 8 486 | -17.2% | 100.0% | 0 | 30 256 382 | -13.9% | 100.0% | 0 | -17.2% |
| GOLDLINE PLUS | 65 341 | 9.4% | 45.4% | -1.2 | 211 436 517 | 11.8% | 37.6% | -0.3 | 12.2% |
| MIGRENIUM | 33 141 | -10.0% | 0.3% | 0 | 11 562 682 | -10.1% | 0.5% | 0 | -4.3% |
| MODELAX-N | 131 900 | 12.7% | 21.1% | 2.5 | 67 843 771 | 14.2% | 14.8% | 1.8 | -0.4% |
| REDUXIN CAPS | 45 654 | 12.6% | 31.7% | 0.1 | 244 184 975 | 11.5% | 43.5% | -0.4 | 12.2% |
| REDUXIN FORTE | 14 054 | 12.6% | 9.8% | 0 | 63 041 555 | 12.9% | 11.2% | 0 | 12.2% |
| SALVISAR | 54 730 | -5.1% | 1.8% | -0.1 | 25 850 376 | -1.0% | 1.7% | 0 | -2.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs